NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 35 filers reported holding NOVARTIS A G in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $151,597 | -0.4% | 1,500 | 0.0% | 0.00% | – |
| Q2 2023 | $152,254 | -16.8% | 1,500 | -24.4% | 0.00% | – |
| Q1 2023 | $182,959 | +34.7% | 1,984 | +32.3% | 0.00% | – |
| Q4 2022 | $135,834 | -15.1% | 1,500 | -29.0% | 0.00% | – |
| Q3 2022 | $160,000 | +26.0% | 2,114 | +40.9% | 0.00% | – |
| Q2 2022 | $127,000 | -3.8% | 1,500 | 0.0% | 0.00% | – |
| Q1 2022 | $132,000 | +7.3% | 1,500 | 0.0% | 0.00% | – |
| Q3 2021 | $123,000 | -9.6% | 1,500 | 0.0% | 0.00% | – |
| Q2 2021 | $136,000 | +6.2% | 1,500 | 0.0% | 0.00% | – |
| Q1 2021 | $128,000 | -9.2% | 1,500 | 0.0% | 0.00% | – |
| Q4 2020 | $141,000 | +7.6% | 1,500 | 0.0% | 0.00% | – |
| Q3 2020 | $131,000 | -0.8% | 1,500 | 0.0% | 0.00% | – |
| Q2 2020 | $132,000 | +6.5% | 1,500 | 0.0% | 0.00% | – |
| Q1 2020 | $124,000 | -12.7% | 1,500 | 0.0% | 0.00% | – |
| Q4 2019 | $142,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXENCIAL WEALTH ADVISORS, LLC | 175,039 | $14,610,000 | 5.98% |
| MANAGED ASSET PORTFOLIOS, LLC | 211,640 | $17,665,000 | 5.83% |
| PRENTISS SMITH & CO INC | 128,894 | $10,759,000 | 5.63% |
| SECTORAL ASSET MANAGEMENT INC | 559,296 | $46,684,000 | 5.10% |
| Osher Van de Voorde Investment Management | 106,515 | $8,891,000 | 4.74% |
| BROWN BROTHERS HARRIMAN & CO | 10,150,549 | $847,266,000 | 4.59% |
| Elefante Mark B | 6,019 | $502,000 | 4.06% |
| PROFESSIONAL ADVISORY SERVICES INC | 223,738 | $18,675,000 | 4.05% |
| First Fiduciary Investment Counsel, Inc. | 245,403 | $20,484,000 | 3.92% |
| COMPASS CAPITAL MANAGEMENT, INC | 282,530 | $23,583,000 | 3.84% |